EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Change in plasma cryptococcal antigen titers in Uganda among outpatients with advanced HIV disease from 2017 to 2022 with rollout of national cryptococcal screening

Alexandra Poeschla iD, Abduljewad Wele, Elizabeth Nalintya, Biyue Dai, David B Meya, David R Boulware iD, Radha Rajasingham iD

PLOS One · 02.06.2026 · 21 (6) · e0349854

DOI: 10.1371/journal.pone.0349854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 02.06.2026. Verfasst von Alexandra Poeschla und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Minnesota Medical School, Minneapolis, Minnesota, United States of America. Hauptthemen laut MEDLINE: Antigens, Fungal, HIV Infections, Meningitis, Cryptococcal, Cryptococcus. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIAID NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cryptococcal meningitis causes an estimated 19% of AIDS-related deaths globally and is the leading cause of meningitis in adults with HIV. Subclinical infection with cryptococcal antigen (CrAg) is detectable in plasma, and CrAg titer of>=1:160 is predictive of meningitis or death. We evaluated if plasma CrAg titer changed over time in Uganda with the expansion of national CrAg screening programs and antiretroviral (ART) access.

Methods

We prospectively screened adults with advanced HIV disease (CD4 ≤ 200 cells/μl) for CrAg from 2017 through 2022 using the lateral flow assay and assessed median plasma CrAg titer.

Results

From November 2017 to May 2022, 436 adults with advanced HIV disease had a positive plasma CrAg test. The median CD4 + cell count was 45 [IQR: 21,94] cells/µL, and median plasma CrAg titer was 1:80 [IQR: 10,1280]. Analysis of median quarterly CrAg titer from 2017–2022 demonstrated a non-statistically significant positive trend in CrAg titer (tau = 0.385, p = 0.086). There was a statistically significant decline in the percentage of participants taking ART at the time of screening (p < 0.001), with 58% reporting never having taken ART in 2022.

Conclusions

Despite expansion of CrAg screening and ART, median annual CrAg titers have not decreased between 2017 and 2022 in Uganda. Contrary to national reporting of expanded access to ART, our study population had higher rates of ART-naïve status over time, suggesting ongoing late presentation to care for people with advanced HIV disease. In addition, the presence of ART-experienced patients in our study population suggests challenges with treatment adherence and retention. Cryptococcosis persists, and despite public health efforts, people are not presenting to care earlier in their disease course. Continued refinement of CrAg screening programs is needed to reduce AIDS-related deaths.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, FungalHIV InfectionsMeningitis, CryptococcalCryptococcusHumansUgandaFemaleAdultMaleMass ScreeningOutpatientsProspective StudiesCD4 Lymphocyte CountMiddle AgedAIDS-Related Opportunistic Infections

Substanzen

Antigens, Fungal

Autor:innen und Institutionen

  • University of Minnesota Medical School, Minneapolis, Minnesota, United States of America.
  • Department of Biostatistics, University of Minnesota School of Public Health, Minneapolis, Minnesota, United States of America.
  • Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

ORCID-Profile: Alexandra Poeschla, David R Boulware, Radha Rajasingham

Förderung

  • NINDS NIH HHS
  • NIAID NIH HHS
  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
  • Foundation for the National Institutes of Health

Zitieren

APA

Poeschla, A., Wele, A., Nalintya, E., Dai, B., Meya, D. B., Boulware, D. R., & Rajasingham, R. (2026). Change in plasma cryptococcal antigen titers in Uganda among outpatients with advanced HIV disease from 2017 to 2022 with rollout of national cryptococcal screening. PLOS One, 21(6), e0349854. https://doi.org/10.1371/journal.pone.0349854

Vancouver

Poeschla A, Wele A, Nalintya E, Dai B, Meya DB, Boulware DR, et al. Change in plasma cryptococcal antigen titers in Uganda among outpatients with advanced HIV disease from 2017 to 2022 with rollout of national cryptococcal screening. PLOS One. 2026;21(6):e0349854. doi:10.1371/journal.pone.0349854

BibTeX
@article{Poeschla2026,
  author = {Poeschla, Alexandra and Wele, Abduljewad and Nalintya, Elizabeth and Dai, Biyue and Meya, David B and Boulware, David R and Rajasingham, Radha},
  title = {Change in plasma cryptococcal antigen titers in Uganda among outpatients with advanced HIV disease from 2017 to 2022 with rollout of national cryptococcal screening},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0349854},
  doi = {10.1371/journal.pone.0349854}
}
Kostenlos starten →